Opko Health Inc Stock News

MIAMI, Jan. 03, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 41st Annual J.P. Morgan Healthcare Conference being held January 9

Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in RAYALDEE.

OPKO Health (OPK) is likely to gain from the potential in RAYALDEE that targets a growing market coupled with new collaborations and acquisitions.

OPKO Health, Inc. (NASDAQ:OPK ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Phillip Frost - Chairman and Chief Executive Of

OPKO Health (OPK) delivered earnings and revenue surprises of -10% and 4.07%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

US crude oil futures traded higher on Friday. Investors, meanwhile, focused on some notable insider trades.

Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in RAYALDEE.

OPKO Health, Inc. revenues and earnings numbers in Q2 both missed estimates. OPKO Health shares continue to fall but the CEO continues to buy.

Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in Rayaldee.

Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in Rayaldee.

MIAMI, Aug. 16, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK), a multinational biopharmaceutical and diagnostics company, today announced that Jon R. Cohen, M.D., is retiring from his rol

Investors shrugged off the company's notably worse-than-expected quarterly results.

Investors shrugged off the company's notably worse-than-expected quarterly results.

OPKO Health's (OPK) second-quarter results benefit from continued strength in its Pharmaceuticals segment.

OPK earnings call for the period ending June 30, 2022.